Use of Flow Focusing® technology to produce tobramycin-loaded plga microparticles for pulmonary drug delivery

Medicinal Chemistry

Volumn 8, Issue 4, 2012, Pages 533-540

  Martín Banderas, Lucia ^a   Holgado, Maria Angeles ^a   Álvarez Fuentes, Josefa ^a   Fernández Arévalo, Mercedes ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Drug delivery systems; Flow Focusing ; Microparticles; Plga; Pulmonary administration; Tobramycin sulphate

Indexed keywords

NANOPARTICLE; POLYMER; SURFACTANT; TOBRAMYCIN;

AEROSOL; ARTICLE; BIODEGRADATION; DENSITY; DRUG DELIVERY SYSTEM; INFECTION; INHALATION; LUNG; LUNG INFECTION; MATHEMATICAL MODEL; POWDER; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SURFACE CHARGE;

ADMINISTRATION, INHALATION; DRUG DELIVERY SYSTEMS; LACTIC ACID; LUNG; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; POLYGLYCOLIC ACID; TOBRAMYCIN;

EID: 84863765315     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612801216409     Document Type: Article

References (26)

1. Gonda, I. The ascent of pulmonary drug delivery. J. Pharm. Sci., 2000, 89, 940-945.
2. Hickey, A. J.; Martonen, T. B.; Yang, Y. Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols. Pharm. Acta Helv., 1996, 71, 185-190.
3. Gonda, I. Targeting by deposition. In: Pharmaceutical Inhalation Aerosol Technology, Hickey, A. J., Ed.; 2nd ed., Marcel Dekker: New York, 2003, pp. 60-80.
4. Lucas, P.; Anderson, K.; Potter, U. J.; Staniforth, J. N. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm. Res., 1999, 16, 1643-1647.
5. Jain, R. A. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21, 2475-2490.
6. Rowe, R. C.; Sheskey, P. J.; Weller, P. J. 2003. Aliphatic Polyesters. In: Handbook of pharmaceutical excipients, Rowe, R. C.; Sheskey, P. J. Weller, P. J., Eds.; Pharmaceutical Press: London, 2003, pp. 19-21.
7. El-Baseir, M. M.; Phipps, M. A.; Kellaway, I. W. Preparation and subsequent degradation of poly (-lactic acid) microspheres suitable for aerosolisation: a physico-chemical study. Int. J. Pharm., 1997, 151, 145-153.
8. Kaye, R. S.; Purewal, T. S.; Alpar, O. Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modifiedrelease delivery of antibodies. J. Pharm. Sci., 2009, 98, 4055-4068.
9. Ratjen, F.; Brockhaus, F.; Angyalosi, G. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review. J. Cyst. Fibros., 2009, 8, 361-369.
10. Martín-Banderas, L.; Fernández-Arévalo, M.; Gañan-Calvo, A. M. Making drops in microencapsulation processes. Lett. Drug Des. Discov., 2010, 7, 300-309.
11. Gañán-Calvo, A. M. Generation of steady liquid microthreads and micron-sized monodisperse sprays in gas streams. Phys. Rev. Lett., 1998, 80, 285-288.
12. Gañán-Calvo, A. M.; Barrero, A. A novel pneumatic technique to generate steady capillary microjets. J. Aerosol. Sci., 1999, 30, 117-125.
13. Rayleigh, L. On the instabilities of jets. Proc. London Math. Soc., 1879, 10, 4-13.
14. Martín-Banderas, L.; Flores-Mosquera, M.; Riesco, P.; Rodríguez-Gil, A.; Cebolla, A.; Chávez de Diego, S.; Gañán-Calvo, A. M. Flow-focusing: a versatile technology to produce size-controlled and specific morphology microparticles. Small., 2005, 1, 688-692.
15. Feng, C. H.; Lin, S. J.; Wu, H. L.; Chen, S. H. Trace analysis of tobramycin in human plasma by derivatization and highperformance liquid chromatography with ultraviolet detection. J. Chromatogr. B, 2002, 780, 349-354.
16. Hombach, J.; Hoyer, H.; Bernkop-Schnürch, A. Thiolated chitosans: Development and in vitro evaluation of an oral tobramycin sulphate delivery system. Eur. J. Pharm. Sci., 2008, 33, 1-8.
17. Martín-Banderas, L.; Flores-Mosquera, M.; Gañan-Calvo, A. M.; Chávez de Diego, S.; Cebolla, A.; Berdún, M. T.; Fernández-García, J. M.; Rodríguez-Gil, A. Towards high-throughput production of uniformly encoded microparticles. Adv. Mater., 2006, 18, 559-564.
18. ®: Physicochemical characterization and protein detection by reversed-phase HPLC. Int. J. Pharm., 2009, 380, 147-154.
19. Dellamary, L.; Tarara, T. E.; Smith, D. J.; Woelk, C. H.; Adractas, A.; Costello, M. L.; Gill, H.; Weers, J. G.; Hollow porous particles in metered dose inhalers. Pharm. Res., 2000, 17, 168-174.
20. Edwards, D. A.; Hanes, J.; Caponetti, G.; Hrhack, J.; Ben-Jebria, A.; Eskew, M. L.; Mintzes, J.; Deaver, D.; Lotan, N.; Langer, R. Large porous particles for pulmonary drug delivery. Science, 1997, 5320, 1868-1872.
21. Sahana, D. K.; Mittal, G.; Bhardwaj, V.; Ravikumar M. N. V. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior In Vitro and In Vivo using estradiol as a model drug. J. Pharm. Sci., 2008, 97, 1530-1542.
22. Ibrahim, M. A.; Ismail, A.; Fetouh, M. I.; Göpferich, A. Stability of insulin during the erosion of poly (lactic acid) and poly (lactic-coglycolic acid) microspheres. J. Control. Rel., 2005, 106, 241-252.
23. Galeska, I.; Kim, T.; Patil, S. D.; Bhardwaj, U.; Chatttopadhyay, D.; Papadimitrakopoulos, F.; Burgess, D. J. Controlled Release of dexamethasone from PLGA microspheres embedded within polyacidcontaining PVA hydrogels. AAPS J., 2005, 7(1), E231-40
24. Choung, H.; Jin, S.; Lee, M. J.; Kim, C.; Hwang, J. Slow-releasing paclitaxel in polytetrafluoroethylene/polylactide-co-glycolide laminate delays adjustment after strabismus surgery in rabbit model. Investig. Ophthalmol. Visual Sci., 2008, 49, 5340-5344.
25. Mittal, G.; Sahana, D. K.; Bhardwaj, V.; Ravi Kumar, M. N. V. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J. Control. Rel., 2007, 119, 77-85.
26. ®. Effects on drug loading and release properties. Int. J. Pharm., 2008, 358, 27-35.